Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Expands By 21.2%
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Expands By 21.2%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant growth in short interest in the month of December. As of December 30th, there was short interest totalling 189,900 shares, a growth of 21.2% from the December 15th total of 156,700 shares. Based on an average daily trading volume, of 1,488,100 shares, the short-interest ratio is presently 0.1 days.
Q 生物醫學股份有限公司（OTCMKTS：QBIO-獲取評級）是在十二月份短期利益顯著增長的接收者。截至十二月三十日，短期利息總共達 189,900 股，較十二月十五日總股 156,700 股股份增長 21.2%。根據 1,488,100 股的平均每日交易量計算，短息比率目前為 0.1 天。
Q BioMed Price Performance
Q 生物醫學價格表現
Shares of QBIO stock opened at $0.01 on Friday. Q BioMed has a 12-month low of $0.01 and a 12-month high of $0.49. The company has a market capitalization of $909,090.00, a PE ratio of -0.04 and a beta of 2.44. The firm has a 50 day moving average price of $0.01 and a two-hundred day moving average price of $0.03.
QBIO 股份於星期五以 0.01 美元開盤。Q 生物醫藥擁有 12 個月低點 0.01 美元和 12 個月高點 0.49 美元。該公司的市值為 909,090.00 美元，聚乙烯比率為 -0.04，測試版為 2.44 美元。該公司的 50 日移動平均價為 0.01 美元，200 日移動平均價為 0.03 美元。
Q BioMed (OTCMKTS:QBIO – Get Rating) last released its earnings results on Thursday, November 3rd. The company reported ($0.03) EPS for the quarter. The business had revenue of $0.03 million for the quarter.
Q 生物醫學（OTCMKTS：QBIO-獲取評級）最後一次公佈了 11 月 3 日（星期四）的盈利業績。該公司報告了本季度每股盈餘 (0.03 美元)。該業務本季度的收入為 0.03 萬美元。
Q BioMed Company Profile
Q 生物醫學公司簡介
Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.
Q BioMed Inc 是一家生物醫學加速和開發公司，專注於生命科學和醫療保健公司的許可，獲取和提供資源。該公司提供氯化鍶 SR89 和 Mestron，這是一種用於治療轉移性骨癌疼痛的放射性藥物治療。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- 免費獲取有關 Q 生物醫學（QBIO）的研究報告
- 市場節拍週的回顧 — 1/16 — 1/20
- 老自治領是否顯示卡車正在擊中剎車？
- 諾德斯特龍將對減價的恐懼放入零售業
- 埃克森美孚股票：在買入點的醒目距離內
- 高股息收益的必和必拓認為中國推動 23 年增長
Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Q 生物醫學日報的最新消息和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Q BioMed 和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。